Thinking of joining a study?

Register your interest

NCT05098340 | RECRUITING | Acute Ischemic Stroke


Circulating circRNA in Acute Ischemic Stroke
Sponsor:

The Affiliated Hospital of Xuzhou Medical University

Brief Summary:

CRAST is to analyze the expression pattern of circular RNA (circRNA) by bioinformatics analysis in patients with acute ischemic stroke and healthy control. The candidate circRNA will be verified as biomarkers for the detection and prognosis of acute ischemic stroke.

Condition or disease

Acute Ischemic Stroke

Intervention/treatment

Quantitative Real-time polymerase chain reaction

Detailed Description:

Circular RNAs have been highlighted to be involved in the pathological process of ischemic stroke (IS). The purpose of this protocol will investigate the expression pattern of circular RNA (circRNA) by bioinformatics analysis in patients with acute ischemic stroke and healthy control. The candidate circRNA will be verified as biomarkers for the detection and prognosis of acute ischemic stroke. Distinctive expression patterns of circRNA will be identified by individual quantitative real time polymerase chain reaction (qRT-PCR). A diagnostic or predictive model will be established using logistic regression. The panel of these altered circRNAs may be associated with acute IS and could serve as a novel diagnostic or predictive method.

Study Type : OBSERVATIONAL
Estimated Enrollment : 500 participants
Official Title : Clinical Significance of Circulating circRNA in Acute Ischemic Stroke (CRAST)
Actual Study Start Date : 2020-10-01
Estimated Primary Completion Date : 2024-10-30
Estimated Study Completion Date : 2024-10-30

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 18 Years
Sexes Eligible for Study: ALL
Criteria
Inclusion Criteria
  • * Aged 18 years or older
  • * Confirmed acute ischemic stroke by a diffusion-weighted imaging-position lesion on magnetic resonance imaging (MRI) and a new lesion on a brain computed tomography (CT) scan
  • * Within 72 hours of symptom onset
  • * Good performance status
  • * Signed an approved informed consents
Exclusion Criteria
  • * a history of hemorrhagic infarction, chronic kidney/liver diseases, peripheral arterial occlusive disease, active malignant disease, and inflammatory or infectious diseases

Circulating circRNA in Acute Ischemic Stroke

Location Details

NCT05098340


Please Choose a site



How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations


RECRUITING

China, Jiangsu

Department of Neurology

Xuzhou, Jiangsu, China,

Loading...